| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PGEN | Common Stock | Options Exercise | +18.9K | +5.68% | 352K | Jan 4, 2023 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PGEN | Restricted Stock Units | Options Exercise | $0 | -18.9K | -100% | $0.00* | 0 | Jan 4, 2023 | Common Stock | 18.9K | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. |
| F2 | The RSUs were granted on January 4, 2019 and have vested in full. |